Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1033-1035

  Puthenparumpil, J J ^a   Keough Ryan, T ^a   Kiberd, M ^a   Lawen, J ^a   Kiberd, B A ^a,b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b AC Dickson ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN; EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RAPAMYCIN; STATIN; TACROLIMUS;

ADULT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY GRAFT; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 17844379252     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.231     Document Type: Conference Paper

References (6)

1. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Managing Dyslipidemias in Kidney Transplant Patients Am J Transpl 4 suppl 7 2004 1
2. H. Holdaas, B. Fellstrom, A.G. Jardine Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicenter, randomized, placebo-controlled trial Lancet 361 2003 2024
3. B.A. Kiberd, T. Keough-Ryan, R. Panek Cardiovascular risk reduction in the outpatient kidney transplant clinic Am J Transpl 3 2003 1393
4. C. Simard, J. Turgeon The pharmacokinetics of ezetimibe Can J Clin Pharmacol 10 suppl A 2003 13A
5. A.Y.Y. Cheng, L.A. Leiter Clinical use of ezetimibe Can J Clin Pharmacol 10 suppl A 2003 21A
6. M.R. Law, N.J. Wald, A.R. Rudnicka Quantifying effect of statins on low density lipoprotein cholesterol, ischeamic heart disease, and stroke: systematic review and meta-analysis BMJ 326 2003 1423